Colitis, Ulcerative - 26 Studies Found Completed : Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-01-25 : Biological: Anrukinzumab 200 m Active, not recruiting : A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis : Colitis, Ulcerative : 2013-07-12 : Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg Completed : The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-12-12 : Drug: Kappaproct 30 mg rectal Recruiting : GSK2982772 Study in Ulcerative Colitis Patients : Colitis, Ulcerative : 2016-09-13 : Drug: GSK2982772 GSK2982772 is RECRUITING : A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis : Colitis, Ulcerative : 2024-09-18 : JNJ-77242113 tablet will be administered orally. COMPLETED : A Study of Vedolizumab in Adults in Real-World Practice : Colitis, Ulcerative : 2024-09-18 <<< Previous